+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 75Years
All Genders
ID04829708

Comparing Prophylactic Cranial Irradiation and MRI Monitoring for Patients with Limited-stage Small Cell Lung Cancer After First-line Chemoradiotherapy

Led by Shandong Cancer Hospital and Institute · Updated on 2021-04-29

534

Participants Needed

2

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a phase III clinical trial to compare two approaches for managing patients with limited-stage small cell lung cancer LS-SCLC who have achieved remission after first-line chemoradiotherapy. The study aims to evaluate the effectiveness and safety of prophylactic cranial irradiation PCI versus MRI surveillance in preventing cancer spread to the brain. While PCI is used to reduce brain metastasis, MRI surveillance may lower side effects and could be similarly effective by delaying radiation until brain metastases appear. Participants are randomly assigned to one of two groups. One group receives PCI with recommended hippocampal protection, delivered within six weeks after first-line treatment at a total dose of 25 Gy over ten sessions. Brain MRI scans are performed every three months for the first two years, then every six months until brain metastases occur. The other group undergoes regular brain MRI scans on the same schedule without PCI, and if brain metastases develop, they receive brain radiotherapy and systemic treatment with continued MRI monitoring. During the study, participants will have ongoing brain MRI scans and clinical assessments to monitor disease progression and side effects. Researchers will measure overall survival up to two years after randomization, along with progression-free survival, rates of brain metastasis, neurocognitive impairment, and one- and three-year survival rates. The study includes careful safety monitoring and follow-up to evaluate the benefits and risks of each approach in this patient population.

CONDITIONS

Brief Title

Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy

Research Team

J

Jinming Yu, PhD

X

Xiangjiao Meng, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here